The global Cardiac Biomarkers Testing market was valued at US$ 7132.7 million in 2023 and is anticipated to reach US$ 11410 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

Cardiac Biomarkers Testing Market

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.

This report aims to provide a comprehensive presentation of the global market for Cardiac Biomarkers Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Biomarkers Testing.

Report Scope

The Cardiac Biomarkers Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Biomarkers Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cardiac Biomarkers Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cardiac Biomarkers Testing Market Report

Report Metric	Details
Report Name	Cardiac Biomarkers Testing Market
Accounted market size in 2023	US$ 7132.7 million
Forecasted market size in 2030	US$ 11410 million
CAGR	6.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Myocardial Muscle Creatine Kinase (CK-MB) Troponins (T and I) Myoglobin Brain Natriuretic Peptide (BNPs) or NT-proBNP Ischemia-modified Albumin (IMA) Others
Segment by Application	Myocardial Infarction Congestive Heart Failure Acute Coronary Syndrome Atherosclerosis Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, ROCHE, Siemens AG, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Tosoh Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Biomarkers Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cardiac Biomarkers Testing Market growing?

Ans: The Cardiac Biomarkers Testing Market witnessing a CAGR of 6.5% during the forecast period 2024-2030.

What is the Cardiac Biomarkers Testing Market size in 2030?

Ans: The Cardiac Biomarkers Testing Market size in 2030 will be US$ 11410 million.

Who are the main players in the Cardiac Biomarkers Testing Market report?

Ans: The main players in the Cardiac Biomarkers Testing Market are Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, ROCHE, Siemens AG, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Tosoh Corporation

What are the Application segmentation covered in the Cardiac Biomarkers Testing Market report?

Ans: The Applications covered in the Cardiac Biomarkers Testing Market report are Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others

What are the Type segmentation covered in the Cardiac Biomarkers Testing Market report?

Ans: The Types covered in the Cardiac Biomarkers Testing Market report are Myocardial Muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia-modified Albumin (IMA), Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Myocardial Muscle Creatine Kinase (CK-MB)

1.2.3 Troponins (T and I)

1.2.4 Myoglobin

1.2.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP

1.2.6 Ischemia-modified Albumin (IMA)

1.2.7 Others

1.3 Market by Application

1.3.1 Global Cardiac Biomarkers Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Myocardial Infarction

1.3.3 Congestive Heart Failure

1.3.4 Acute Coronary Syndrome

1.3.5 Atherosclerosis

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cardiac Biomarkers Testing Market Perspective (2019-2030)

2.2 Cardiac Biomarkers Testing Growth Trends by Region

2.2.1 Global Cardiac Biomarkers Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cardiac Biomarkers Testing Historic Market Size by Region (2019-2024)

2.2.3 Cardiac Biomarkers Testing Forecasted Market Size by Region (2025-2030)

2.3 Cardiac Biomarkers Testing Market Dynamics

2.3.1 Cardiac Biomarkers Testing Industry Trends

2.3.2 Cardiac Biomarkers Testing Market Drivers

2.3.3 Cardiac Biomarkers Testing Market Challenges

2.3.4 Cardiac Biomarkers Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cardiac Biomarkers Testing Players by Revenue

3.1.1 Global Top Cardiac Biomarkers Testing Players by Revenue (2019-2024)

3.1.2 Global Cardiac Biomarkers Testing Revenue Market Share by Players (2019-2024)

3.2 Global Cardiac Biomarkers Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cardiac Biomarkers Testing Revenue

3.4 Global Cardiac Biomarkers Testing Market Concentration Ratio

3.4.1 Global Cardiac Biomarkers Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Testing Revenue in 2023

3.5 Cardiac Biomarkers Testing Key Players Head office and Area Served

3.6 Key Players Cardiac Biomarkers Testing Product Solution and Service

3.7 Date of Enter into Cardiac Biomarkers Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cardiac Biomarkers Testing Breakdown Data by Type

4.1 Global Cardiac Biomarkers Testing Historic Market Size by Type (2019-2024)

4.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2025-2030)

5 Cardiac Biomarkers Testing Breakdown Data by Application

5.1 Global Cardiac Biomarkers Testing Historic Market Size by Application (2019-2024)

5.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cardiac Biomarkers Testing Market Size (2019-2030)

6.2 North America Cardiac Biomarkers Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cardiac Biomarkers Testing Market Size by Country (2019-2024)

6.4 North America Cardiac Biomarkers Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cardiac Biomarkers Testing Market Size (2019-2030)

7.2 Europe Cardiac Biomarkers Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cardiac Biomarkers Testing Market Size by Country (2019-2024)

7.4 Europe Cardiac Biomarkers Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cardiac Biomarkers Testing Market Size (2019-2030)

8.2 Asia-Pacific Cardiac Biomarkers Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cardiac Biomarkers Testing Market Size (2019-2030)

9.2 Latin America Cardiac Biomarkers Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cardiac Biomarkers Testing Market Size by Country (2019-2024)

9.4 Latin America Cardiac Biomarkers Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cardiac Biomarkers Testing Market Size (2019-2030)

10.2 Middle East & Africa Cardiac Biomarkers Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Cardiac Biomarkers Testing Introduction

11.1.4 Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.1.5 Abbott Laboratories Recent Development

11.2 Becton, Dickinson and Company

11.2.1 Becton, Dickinson and Company Company Detail

11.2.2 Becton, Dickinson and Company Business Overview

11.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Introduction

11.2.4 Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.2.5 Becton, Dickinson and Company Recent Development

11.3 BioMerieux

11.3.1 BioMerieux Company Detail

11.3.2 BioMerieux Business Overview

11.3.3 BioMerieux Cardiac Biomarkers Testing Introduction

11.3.4 BioMerieux Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.3.5 BioMerieux Recent Development

11.4 Bio-Rad Laboratories, Inc.

11.4.1 Bio-Rad Laboratories, Inc. Company Detail

11.4.2 Bio-Rad Laboratories, Inc. Business Overview

11.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Introduction

11.4.4 Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.4.5 Bio-Rad Laboratories, Inc. Recent Development

11.5 Danaher Corporation

11.5.1 Danaher Corporation Company Detail

11.5.2 Danaher Corporation Business Overview

11.5.3 Danaher Corporation Cardiac Biomarkers Testing Introduction

11.5.4 Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.5.5 Danaher Corporation Recent Development

11.6 ROCHE

11.6.1 ROCHE Company Detail

11.6.2 ROCHE Business Overview

11.6.3 ROCHE Cardiac Biomarkers Testing Introduction

11.6.4 ROCHE Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.6.5 ROCHE Recent Development

11.7 Siemens AG

11.7.1 Siemens AG Company Detail

11.7.2 Siemens AG Business Overview

11.7.3 Siemens AG Cardiac Biomarkers Testing Introduction

11.7.4 Siemens AG Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.7.5 Siemens AG Recent Development

11.8 Thermo Fisher Scientific, Inc.

11.8.1 Thermo Fisher Scientific, Inc. Company Detail

11.8.2 Thermo Fisher Scientific, Inc. Business Overview

11.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Introduction

11.8.4 Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.8.5 Thermo Fisher Scientific, Inc. Recent Development

11.9 PerkinElmer Inc.

11.9.1 PerkinElmer Inc. Company Detail

11.9.2 PerkinElmer Inc. Business Overview

11.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Introduction

11.9.4 PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.9.5 PerkinElmer Inc. Recent Development

11.10 Tosoh Corporation

11.10.1 Tosoh Corporation Company Detail

11.10.2 Tosoh Corporation Business Overview

11.10.3 Tosoh Corporation Cardiac Biomarkers Testing Introduction

11.10.4 Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024)

11.10.5 Tosoh Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott Laboratories

Becton Dickinson and Company

Biomerieux

Bio-Rad Laboratories Inc

Danaher Corporation

Roche

Siemens AG

Thermo Fisher Scientific Inc

PerkinElmer Inc

Tosoh Corporation

List of Tables

Table 1. Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Myocardial Muscle Creatine Kinase (CK-MB)

Table 3. Key Players of Troponins (T and I)

Table 4. Key Players of Myoglobin

Table 5. Key Players of Brain Natriuretic Peptide (BNPs) or NT-proBNP

Table 6. Key Players of Ischemia-modified Albumin (IMA)

Table 7. Key Players of Others

Table 8. Global Cardiac Biomarkers Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Cardiac Biomarkers Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Cardiac Biomarkers Testing Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Cardiac Biomarkers Testing Market Share by Region (2019-2024)

Table 12. Global Cardiac Biomarkers Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Cardiac Biomarkers Testing Market Share by Region (2025-2030)

Table 14. Cardiac Biomarkers Testing Market Trends

Table 15. Cardiac Biomarkers Testing Market Drivers

Table 16. Cardiac Biomarkers Testing Market Challenges

Table 17. Cardiac Biomarkers Testing Market Restraints

Table 18. Global Cardiac Biomarkers Testing Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Cardiac Biomarkers Testing Market Share by Players (2019-2024)

Table 20. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Biomarkers Testing as of 2023)

Table 21. Ranking of Global Top Cardiac Biomarkers Testing Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Cardiac Biomarkers Testing Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Cardiac Biomarkers Testing Product Solution and Service

Table 25. Date of Enter into Cardiac Biomarkers Testing Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Cardiac Biomarkers Testing Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2019-2024)

Table 29. Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2025-2030)

Table 31. Global Cardiac Biomarkers Testing Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Cardiac Biomarkers Testing Revenue Market Share by Application (2019-2024)

Table 33. Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Cardiac Biomarkers Testing Revenue Market Share by Application (2025-2030)

Table 35. North America Cardiac Biomarkers Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Cardiac Biomarkers Testing Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Cardiac Biomarkers Testing Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Cardiac Biomarkers Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Cardiac Biomarkers Testing Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Cardiac Biomarkers Testing Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Cardiac Biomarkers Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Cardiac Biomarkers Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Cardiac Biomarkers Testing Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Cardiac Biomarkers Testing Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Cardiac Biomarkers Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2025-2030) & (US$ Million)

Table 50. Abbott Laboratories Company Detail

Table 51. Abbott Laboratories Business Overview

Table 52. Abbott Laboratories Cardiac Biomarkers Testing Product

Table 53. Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 54. Abbott Laboratories Recent Development

Table 55. Becton, Dickinson and Company Company Detail

Table 56. Becton, Dickinson and Company Business Overview

Table 57. Becton, Dickinson and Company Cardiac Biomarkers Testing Product

Table 58. Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 59. Becton, Dickinson and Company Recent Development

Table 60. BioMerieux Company Detail

Table 61. BioMerieux Business Overview

Table 62. BioMerieux Cardiac Biomarkers Testing Product

Table 63. BioMerieux Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 64. BioMerieux Recent Development

Table 65. Bio-Rad Laboratories, Inc. Company Detail

Table 66. Bio-Rad Laboratories, Inc. Business Overview

Table 67. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Product

Table 68. Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 69. Bio-Rad Laboratories, Inc. Recent Development

Table 70. Danaher Corporation Company Detail

Table 71. Danaher Corporation Business Overview

Table 72. Danaher Corporation Cardiac Biomarkers Testing Product

Table 73. Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 74. Danaher Corporation Recent Development

Table 75. ROCHE Company Detail

Table 76. ROCHE Business Overview

Table 77. ROCHE Cardiac Biomarkers Testing Product

Table 78. ROCHE Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 79. ROCHE Recent Development

Table 80. Siemens AG Company Detail

Table 81. Siemens AG Business Overview

Table 82. Siemens AG Cardiac Biomarkers Testing Product

Table 83. Siemens AG Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 84. Siemens AG Recent Development

Table 85. Thermo Fisher Scientific, Inc. Company Detail

Table 86. Thermo Fisher Scientific, Inc. Business Overview

Table 87. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Product

Table 88. Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 89. Thermo Fisher Scientific, Inc. Recent Development

Table 90. PerkinElmer Inc. Company Detail

Table 91. PerkinElmer Inc. Business Overview

Table 92. PerkinElmer Inc. Cardiac Biomarkers Testing Product

Table 93. PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 94. PerkinElmer Inc. Recent Development

Table 95. Tosoh Corporation Company Detail

Table 96. Tosoh Corporation Business Overview

Table 97. Tosoh Corporation Cardiac Biomarkers Testing Product

Table 98. Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)

Table 99. Tosoh Corporation Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cardiac Biomarkers Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cardiac Biomarkers Testing Market Share by Type: 2023 VS 2030

Figure 3. Myocardial Muscle Creatine Kinase (CK-MB) Features

Figure 4. Troponins (T and I) Features

Figure 5. Myoglobin Features

Figure 6. Brain Natriuretic Peptide (BNPs) or NT-proBNP Features

Figure 7. Ischemia-modified Albumin (IMA) Features

Figure 8. Others Features

Figure 9. Global Cardiac Biomarkers Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Cardiac Biomarkers Testing Market Share by Application: 2023 VS 2030

Figure 11. Myocardial Infarction Case Studies

Figure 12. Congestive Heart Failure Case Studies

Figure 13. Acute Coronary Syndrome Case Studies

Figure 14. Atherosclerosis Case Studies

Figure 15. Others Case Studies

Figure 16. Cardiac Biomarkers Testing Report Years Considered

Figure 17. Global Cardiac Biomarkers Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Cardiac Biomarkers Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Cardiac Biomarkers Testing Market Share by Region: 2023 VS 2030

Figure 20. Global Cardiac Biomarkers Testing Market Share by Players in 2023

Figure 21. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Biomarkers Testing as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Cardiac Biomarkers Testing Revenue in 2023

Figure 23. North America Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Cardiac Biomarkers Testing Market Share by Country (2019-2030)

Figure 25. United States Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Cardiac Biomarkers Testing Market Share by Country (2019-2030)

Figure 29. Germany Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Cardiac Biomarkers Testing Market Share by Region (2019-2030)

Figure 37. China Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Cardiac Biomarkers Testing Market Share by Country (2019-2030)

Figure 45. Mexico Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Cardiac Biomarkers Testing Market Share by Country (2019-2030)

Figure 49. Turkey Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Abbott Laboratories Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 53. BioMerieux Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 54. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 55. Danaher Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 56. ROCHE Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 57. Siemens AG Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 58. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 59. PerkinElmer Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 60. Tosoh Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-35Y14435

Tue Nov 12 00:00:00 UTC 2024

Add to Cart

Self-adhesive Pain Relief Patches - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19Y14090

Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Stereotactic Radiosurgery (SRS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14C14333

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Vascular Surgery Magnifier - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-23I17442

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cardiac Biomarkers Testing Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-22Z5795

Global Cardiac Biomarkers Testing Market Research Report 2024

FEATURED COMPANIES

Cardiac Biomarkers Testing Market Size

Cardiac Biomarkers Testing Market

Report Scope

Scope of Cardiac Biomarkers Testing Market Report

Chapter Outline

FAQ for this report

How fast is Cardiac Biomarkers Testing Market growing?

What is the Cardiac Biomarkers Testing Market size in 2030?

Who are the main players in the Cardiac Biomarkers Testing Market report?

What are the Application segmentation covered in the Cardiac Biomarkers Testing Market report?

What are the Type segmentation covered in the Cardiac Biomarkers Testing Market report?

FEATURED COMPANIES

RELATED REPORTS